Asia Africa Investment & Consulting (AAIC)
ActiveVenture Capital
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at Asia Africa Investment & Consulting (AAIC).
Key people at Asia Africa Investment & Consulting (AAIC).
Key people at Asia Africa Investment & Consulting (AAIC).
Asia Africa Investment & Consulting (AAIC) is a Singapore-based investment and consulting firm primarily focused on driving growth in the healthcare sector across Africa. Their mission centers on investing in fast-growing healthcare companies to provide growth capital and long-term value, aiming to improve company performance and expansion while fostering sustainable economic development. AAIC leverages a unique synergy by combining Japan’s strengths—people, funds, knowledge, and information—with the growth potential of developing countries, particularly in Africa. This approach supports a mutually beneficial relationship between Japan and these emerging markets. AAIC also facilitates mergers and acquisitions and operates global research networks to enhance corporate growth and innovation in novel industries[1][2][3][4].
Founded in 2013, AAIC has evolved to manage specialized funds such as the African Healthcare Fund and the Africa Innovation & Healthcare Fund, targeting innovative startups and companies in healthcare and related sectors. The firm’s portfolio includes companies recognized among Africa’s fastest-growing firms, reflecting its impact on the startup ecosystem by supporting early-stage companies through strategic consultations, business plan optimization, and fostering resilience during challenges like the COVID-19 pandemic. AAIC’s network spans over 170 local researchers in 80 countries, enabling deep market insights and operational support for portfolio companies[1][4][5].
AAIC was established in 2013 in Singapore with a vision to bridge investment and knowledge between Asia—particularly Japan—and Africa’s emerging markets. Key partners include executives such as CEO Susumu Tsubaki and directors like Shigeru Handa, who have guided the firm’s focus on healthcare and innovation sectors. The firm’s evolution reflects a growing emphasis on healthcare innovation and digital health startups in Africa, responding to market needs and leveraging Japan’s technological and financial strengths to support sustainable growth in developing countries[4][5][8].
AAIC rides the wave of increasing digitalization and healthcare innovation in Africa, a continent experiencing rapid startup ecosystem growth. The timing is critical as African healthcare markets expand and require capital and expertise to scale solutions addressing local health challenges. Market forces such as rising demand for health tech, fintech integration, and government/donor support for startups create a favorable environment. AAIC influences the ecosystem by bridging Asian capital and knowledge with African innovation, fostering cross-border partnerships, and supporting startups to become resilient and scalable businesses[4][5].
Looking ahead, AAIC is poised to deepen its impact by expanding its healthcare-focused funds and supporting startups that leverage digital health and fintech innovations. Trends such as increased digital adoption, public-private partnerships, and growing startup ecosystems in Africa will shape their journey. AAIC’s role may evolve to become a critical connector between Asian investors and African innovators, helping to scale solutions that address healthcare and social challenges sustainably. Their continued focus on strategic partnerships and operational support will likely enhance their influence in shaping Africa’s healthcare and innovation landscape[4][5].
In summary, AAIC stands out as a strategic investment and consulting firm that leverages cross-continental synergies to foster healthcare innovation and sustainable growth in Africa, aligning with broader trends of digital transformation and emerging market development.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 1, 2023 | Helium Health | $30.0M Series B | — | Angel Labs, AV8 Ventures, B Capital Group, Cantos Ventures, Ali Tamaseb, Global Ventures, Maven Ventures, Y Combinator, Anne Wojcicki, Tony Xu |
| Nov 1, 2021 | DrugStoc | $4.0M Series A | — | — |
| Sep 1, 2020 | Rology | $860K Seed | — | — |
| Apr 1, 2020 | Helium Health | $10.0M Series A | — | Angel Labs, AV8 Ventures, Cantos Ventures, Global Ventures, Y Combinator, Anne Wojcicki, Tony Xu |
